LD-2 disclosure · 2nd Quarter - Report
MALLINCKRODT PHARMACEUTICALS
Client
- Description
- Mallinckrodt Pharmaceuticals manufactures specialty products and diagnostics
- Location
- Missouri · United States of America
Registrant
- Description
- Health care policy and regulatory and legislative consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
Medicaid drug rebate program
LobbyistsRAISSA H DOWNS · JENNIFER B YOUNG · MICHELLE P EASTON · ELIZABETH T MURRAY · CHARLOTTE SPEARS IVANCIC · PAMELA SMITH · EMILY H MURRY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Budget/Appropriations
debt ceiling, appropriations H.R. 2740 - HHS Appropriations, 2020 H.R. 3164 - FDA Appropriations, 2020 H.R. 4378 - Continuing Appropriations Act and Health Extenders Act H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act
LobbyistsRAISSA H DOWNS · JENNIFER B YOUNG · MICHELLE P EASTON · ELIZABETH T MURRAY · CHARLOTTE SPEARS IVANCIC · PAMELA SMITH · EMILY H MURRY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Health Issues
prescription drug abuse and deterrence, non-interference H.R. 269 - PAHPA Reauthorization of 2019 S. 1416 - Affordable Prescriptions For Patients Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201 - Families First Coronavirus Response Act S. 3548 - CARES Act H.R. 6800 - The Heroes Act no specific bills, drug pricing and innovation
